[1]
Ashida, A. et al. 2017. Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Acta Dermato-Venereologica. 97, 10 (Aug. 2017), 1212–1218. DOI:https://doi.org/10.2340/00015555-2748.